EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Astragaloside IV Blunts Epithelial–Mesenchymal Transition and G2/M Arrest to Alleviate Renal Fibrosis via Regulating ALDH2-Mediated Autophagy

Dong Li, Yuzhe Liu iD, Quancao Zhan, Yan Zeng, Ze Peng, Qifeng He, Qi Tan, Wenfu Cao, Shang Wang, Jianwei Wang

Cells · 2023

DOI: 10.3390/cells12131777 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cells, 2023. Verfasst von Dong Li und 9 weiteren Autor:innen. Beteiligte Einrichtung: Chongqing Key Laboratory of Traditional Chinese Medicine for Prevention and Cure of Metabolic Diseases, College of Traditional Chinese Medicine, Chon…. Hauptthemen laut MEDLINE: Transforming Growth Factor beta1, Renal Insufficiency, Chronic. Die Arbeit wurde bisher 24-mal zitiert (Crossref) und nennt 87 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Innovation Team Program of Chongqing Traditional Chinese Medicine, Xinglin program of Chongqing TCM/TCM-integrated Key discipline.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Previous studies show that astragaloside IV (ASIV) has anti-renal fibrosis effects. However, its mechanism remains elusive. In this study, we investigated the anti-fibrosis mechanisms of ASIV on chronic kidney disease (CKD) in vivo and in vitro. A CKD model was induced in rats with adenine (200 mg/kg/d, i.g.), and an in vitro renal fibrosis model was induced in human kidney-2 (HK-2) cells treated with TGF-β1. We revealed that ASIV significantly alleviated renal fibrosis by suppressing the expressions of epithelial–mesenchymal transition (EMT)-related proteins, including fibronectin, vimentin, and alpha-smooth muscle actin (α-SMA), and G2/M arrest-related proteins, including phosphorylated p53 (p-p53), p21, phosphorylated histone H3 (p-H3), and Ki67 in both of the in vivo and in vitro models. Transcriptomic analysis and subsequent validation showed that ASIV rescued ALDH2 expression and inhibited AKT/mTOR-mediated autophagy. Furthermore, in ALDH2-knockdown HK-2 cells, ASIV failed to inhibit AKT/mTOR-mediated autophagy and could not blunt EMT and G2/M arrest. In addition, we further demonstrated that rapamycin, an autophagy inducer, reversed the treatment of ASIV by promoting autophagy in TGF-β1-treated HK-2 cells. A dual-luciferase report assay indicated that ASIV enhanced the transcriptional activity of the ALDH2 promoter. In addition, a further molecular docking analysis showed the potential interaction of ALDH2 and ASIV. Collectively, our data indicate that ALDH2-mediated autophagy may be a novel target in treating renal fibrosis in CKD models, and ASIV may be an effective targeted drug for ALDH2, which illuminate a new insight into the treatment of renal fibrosis and provide new evidence of pharmacology to elucidate the anti-fibrosis mechanism of ASIV in treating renal fibrosis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Transforming Growth Factor beta1Renal Insufficiency, ChronicRatsHumansAnimalsEpithelial-Mesenchymal TransitionProto-Oncogene Proteins c-aktApoptosisMolecular Docking SimulationTumor Suppressor Protein p53Cell Line, TumorG2 Phase Cell Cycle CheckpointsFibrosisTOR Serine-Threonine KinasesAutophagyAldehyde Dehydrogenase, MitochondrialSaponinsTriterpenes

Stichwörter der Autor:innen

AKT/mTORALDH2astragaloside IVautophagyrenal fibrosis

Substanzen

Transforming Growth Factor beta1Proto-Oncogene Proteins c-aktTumor Suppressor Protein p53TOR Serine-Threonine KinasesAldehyde Dehydrogenase, Mitochondrialastragaloside ASaponinsTriterpenesALDH2 protein, human

Autor:innen und Institutionen

  • Chongqing Key Laboratory of Traditional Chinese Medicine for Prevention and Cure of Metabolic Diseases, College of Traditional Chinese Medicine, Chongqing Medical University, Chongqing 400016, China.
  • College of Basic Medical Sciences, Chongqing Medical University, Chongqing 400016, China.

ORCID-Profile: Yuzhe Liu

Förderung

  • Innovation Team Program of Chongqing Traditional Chinese Medicine
  • Xinglin program of Chongqing TCM/TCM-integrated Key discipline

Zitieren

APA

Li, D., Liu, Y., Zhan, Q., Zeng, Y., Peng, Z., He, Q., Tan, Q., Cao, W., Wang, S., & Wang, J. (2023). Astragaloside IV Blunts Epithelial–Mesenchymal Transition and G2/M Arrest to Alleviate Renal Fibrosis via Regulating ALDH2-Mediated Autophagy. Cells. https://doi.org/10.3390/cells12131777

Vancouver

Li D, Liu Y, Zhan Q, Zeng Y, Peng Z, He Q, et al. Astragaloside IV Blunts Epithelial–Mesenchymal Transition and G2/M Arrest to Alleviate Renal Fibrosis via Regulating ALDH2-Mediated Autophagy. Cells. 2023. doi:10.3390/cells12131777

BibTeX
@article{Li2023,
  author = {Li, Dong and Liu, Yuzhe and Zhan, Quancao and Zeng, Yan and Peng, Ze and He, Qifeng and Tan, Qi and Cao, Wenfu and Wang, Shang and Wang, Jianwei},
  title = {Astragaloside IV Blunts Epithelial–Mesenchymal Transition and G2/M Arrest to Alleviate Renal Fibrosis via Regulating ALDH2-Mediated Autophagy},
  journal = {Cells},
  year = {2023},
  doi = {10.3390/cells12131777}
}
Kostenlos starten →